FH and nonpapillary renal cell carcinoma: These findings align with observations in fumarate hydratase (FH)-deficient ccRCC subtypes, where FH loss leads to fumarate accumulation—a potent inhibitor of prolyl hydroxylases (PHDs) that stabilizes HIF-α even under normoxia [100].